Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity
Summary: Accumulation of visceral adiposity is directly linked to the morbidity of obesity, while subcutaneous body fat is considered more benign. We have identified an unexpected role for B cell lymphoma 6 (BCL6), a critical regulator of immunity, in the developmental expansion of subcutaneous adip...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-12-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718318503 |
id |
doaj-23f24c5f8f9c4498af7deb99b8eddc75 |
---|---|
record_format |
Article |
spelling |
doaj-23f24c5f8f9c4498af7deb99b8eddc752020-11-24T21:40:39ZengElsevierCell Reports2211-12472018-12-01251232833298.e6Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of ObesityMadhavi D. Senagolage0Meredith A. Sommars1Krithika Ramachandran2Christopher R. Futtner3Yasuhiro Omura4Amanda L. Allred5Jianing Wang6Cynthia Yang7Daniele Procissi8Ronald M. Evans9Xianlin Han10Ilya R. Bederman11Grant D. Barish12Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USABarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78245, USACenter for Translational Imaging, Departments of Radiology and Biomedical Engineering, Northwestern University, Chicago, IL 60611, USACenter for Translational Imaging, Departments of Radiology and Biomedical Engineering, Northwestern University, Chicago, IL 60611, USAHoward Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037, USABarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX 78245, USADepartment of Pediatrics, Case Western Reserve University, Cleveland, OH 44106, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA; Corresponding authorSummary: Accumulation of visceral adiposity is directly linked to the morbidity of obesity, while subcutaneous body fat is considered more benign. We have identified an unexpected role for B cell lymphoma 6 (BCL6), a critical regulator of immunity, in the developmental expansion of subcutaneous adipose tissue. In adipocyte-specific knockout mice (Bcl6AKO), we found that Bcl6 deletion results in strikingly increased inguinal, but not perigonadal, adipocyte size and tissue mass in addition to marked insulin sensitivity. Genome-wide RNA expression and DNA binding analyses revealed that BCL6 controls gene networks involved in cell growth and fatty acid biosynthesis. Using deuterium label incorporation and comprehensive adipokine and lipid profiling, we discovered that ablation of adipocyte Bcl6 enhances subcutaneous adipocyte lipogenesis, increases levels of adiponectin and fatty acid esters of hydroxy fatty acids (FAHFAs), and prevents steatosis. Thus, our studies identify BCL6 as a negative regulator of subcutaneous adipose tissue expansion and metabolic health. : Senagolage et al. identify BCL6 as a key regulator of body fat distribution. BCL6 directly represses fatty acid biosynthetic and growth genes in adipocytes. Mice constitutively lacking adipocyte Bcl6 exhibit expansion of their subcutaneous adipose tissue, enhanced insulin sensitivity, and protection from hepatic steatosis. Keywords: obesity, BCL6, BCL-6, repressor, adipocyte, hypertrophy, subcutaneous fat, insulin sensitivity, lipogenesis, adipose tissue, FAHFA, fatty acid esters of hydroxy fatty acids, PAHSA, adiponectin, ceramidehttp://www.sciencedirect.com/science/article/pii/S2211124718318503 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Madhavi D. Senagolage Meredith A. Sommars Krithika Ramachandran Christopher R. Futtner Yasuhiro Omura Amanda L. Allred Jianing Wang Cynthia Yang Daniele Procissi Ronald M. Evans Xianlin Han Ilya R. Bederman Grant D. Barish |
spellingShingle |
Madhavi D. Senagolage Meredith A. Sommars Krithika Ramachandran Christopher R. Futtner Yasuhiro Omura Amanda L. Allred Jianing Wang Cynthia Yang Daniele Procissi Ronald M. Evans Xianlin Han Ilya R. Bederman Grant D. Barish Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity Cell Reports |
author_facet |
Madhavi D. Senagolage Meredith A. Sommars Krithika Ramachandran Christopher R. Futtner Yasuhiro Omura Amanda L. Allred Jianing Wang Cynthia Yang Daniele Procissi Ronald M. Evans Xianlin Han Ilya R. Bederman Grant D. Barish |
author_sort |
Madhavi D. Senagolage |
title |
Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity |
title_short |
Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity |
title_full |
Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity |
title_fullStr |
Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity |
title_full_unstemmed |
Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity |
title_sort |
loss of transcriptional repression by bcl6 confers insulin sensitivity in the setting of obesity |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2018-12-01 |
description |
Summary: Accumulation of visceral adiposity is directly linked to the morbidity of obesity, while subcutaneous body fat is considered more benign. We have identified an unexpected role for B cell lymphoma 6 (BCL6), a critical regulator of immunity, in the developmental expansion of subcutaneous adipose tissue. In adipocyte-specific knockout mice (Bcl6AKO), we found that Bcl6 deletion results in strikingly increased inguinal, but not perigonadal, adipocyte size and tissue mass in addition to marked insulin sensitivity. Genome-wide RNA expression and DNA binding analyses revealed that BCL6 controls gene networks involved in cell growth and fatty acid biosynthesis. Using deuterium label incorporation and comprehensive adipokine and lipid profiling, we discovered that ablation of adipocyte Bcl6 enhances subcutaneous adipocyte lipogenesis, increases levels of adiponectin and fatty acid esters of hydroxy fatty acids (FAHFAs), and prevents steatosis. Thus, our studies identify BCL6 as a negative regulator of subcutaneous adipose tissue expansion and metabolic health. : Senagolage et al. identify BCL6 as a key regulator of body fat distribution. BCL6 directly represses fatty acid biosynthetic and growth genes in adipocytes. Mice constitutively lacking adipocyte Bcl6 exhibit expansion of their subcutaneous adipose tissue, enhanced insulin sensitivity, and protection from hepatic steatosis. Keywords: obesity, BCL6, BCL-6, repressor, adipocyte, hypertrophy, subcutaneous fat, insulin sensitivity, lipogenesis, adipose tissue, FAHFA, fatty acid esters of hydroxy fatty acids, PAHSA, adiponectin, ceramide |
url |
http://www.sciencedirect.com/science/article/pii/S2211124718318503 |
work_keys_str_mv |
AT madhavidsenagolage lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT meredithasommars lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT krithikaramachandran lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT christopherrfuttner lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT yasuhiroomura lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT amandalallred lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT jianingwang lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT cynthiayang lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT danieleprocissi lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT ronaldmevans lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT xianlinhan lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT ilyarbederman lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity AT grantdbarish lossoftranscriptionalrepressionbybcl6confersinsulinsensitivityinthesettingofobesity |
_version_ |
1725925290409984000 |